Logo
x

Search

Subscribe Now

All Posts by Date

PharmaShots Interview: Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer

PharmaShots Interview: Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Canc...

  • August 2, 2022
Caris Life Sciences Entered into a Multi-Year Strategic Option and License Agreement with Xencor for Novel XmAb Bispecific Antibodies to Treat Cancer

Caris Life Sciences Entered into a Multi-Year Strategic Option and License Agreement with Xencor for Novel XmAb Bispecific Antibod...

  • August 2, 2022
Marius’ Kyzatrex (testosterone undecanoate) Receives the US FDA’s Approval for the Treatment of Hypogonadism

Marius’ Kyzatrex (testosterone undecanoate) Receives the US FDA’s Approval for the Treatment of Hypogonadism

  • August 2, 2022
Roche Reports P-III (IMscin001) Study Results of Subcutaneous Formulation of Tecentriq for the Treatment of Non-Small Cell Lung Cancer

Roche Reports P-III (IMscin001) Study Results of Subcutaneous Formulation of Tecentriq for the Treatment of Non-Small Cell Lung Ca...

  • August 2, 2022
Nyxoah Entered into a Distribution Agreement with Acurable for AcuPebble SA100 Home Sleep Test to Treat Obstructive Sleep Apnea in Germany

Nyxoah Entered into a Distribution Agreement with Acurable for AcuPebble SA100 Home Sleep Test to Treat Obstructive Sleep Apnea in...

  • August 2, 2022
Janssen's Stelara (ustekinumab) Receives the US FDA's Approval for the Treatment of Active Psoriatic Arthritis in Pediatric Patients

Janssen's Stelara (ustekinumab) Receives the US FDA's Approval for the Treatment of Active Psoriatic Arthritis in Pediatric Patien...

  • August 2, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.